Fibroblast Growth Factor 11 Enables Tumor Cell Immune Escape by Promoting T Cell Exhaustion and Predicts Poor Prognosis in Patients with Lung Adenocarcinoma

<div>FGF11 expression in different patient groups evaluated based on clinical parameters using the UALCAN database. (a) FGF11 expression in patients with different TNM staging, pathological progression, age, and sex. (b) Forest map of FGF11 expression based on the clinical data in UALCAN database.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Fibroblast Growth Factor 11 Enables Tumor Cell Immune Escape by Promoting T Cell Exhaustion and Predicts Poor Prognosis in Patients with Lung Adenocarcinoma 

Figure 2 | Fibroblast Growth Factor 11 Enables Tumor Cell Immune Escape by Promoting T Cell Exhaustion and Predicts Poor Prognosis in Patients with Lung Adenocarcinoma 